0.335
0.02 (4.79%)
| Penutupan Terdahulu | 0.320 |
| Buka | 0.321 |
| Jumlah Dagangan | 1,130,517 |
| Purata Dagangan (3B) | 1,075,287 |
| Modal Pasaran | 33,086,810 |
| Harga / Jualan (P/S) | 24.34 |
| Harga / Buku (P/B) | 4.49 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 Aug 2025 - 11 Aug 2025 |
| Margin Operasi (TTM) | -443.03% |
| EPS Cair (TTM) | -0.090 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 11.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.76% |
| Nisbah Semasa (MRQ) | 1.28 |
| Aliran Tunai Operasi (OCF TTM) | -4.79 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.91 M |
| Pulangan Atas Aset (ROA TTM) | -49.91% |
| Pulangan Atas Ekuiti (ROE TTM) | -104.33% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | IGC Pharma, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.13 |
|
IGC Pharma, Inc., a clinical stage biotechnology company, engages in developing cannabinoid-based formulations for treating diseases and conditions, including Alzheimer's disease, dysmenorrhea, premenstrual syndrome, and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief, a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 9.16% |
| % Dimiliki oleh Institusi | 19.89% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Dearborn Partners Llc | 31 Dec 2025 | 84,401 |
| Lawood & Co | 31 Mar 2026 | 75,000 |
| Truist Financial Corp | 31 Mar 2026 | 36,667 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |